Legend Biotech Corporation

LEGN

LEGNLegend Biotech Corporation US flag

NASDAQ Global Select

35.98

USD

-0.30

- -

6.65BMarket Cap

Profitability (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-37.1	-52.76	-43.83	-36.43	-32.6	-10.06	-17.44
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	44.14	49.42	62.6	60.34
EBITDA Margin (%)	-27.25	-227.21	-289.15	-549.75	-373.68	-178.74	-45.93	-10.46
Operating Margin (%)	-30.68	-236.39	-302.39	-569.97	-389.4	-185.23	-49.34	-13.27
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-3.29	-227.66	-411.05	-591.63	-380.94	-182.46	-25.2	-27.47
Profit Margin (%)	-5.67	-232.21	-355.16	-586.38	-381.48	-181.8	-28.22	-28.85
Net Income to Common Margin (%)	-5.67	-232.21	-355.16	-586.38	-381.48	-181.8	-28.22	-28.85
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	4	6	3	123	285	329	351	414
ST Debt	- -	1	1	1	4	3	5	326
LT Debt	4	5	2	122	281	325	346	87
Total Debt/EBITDA	-0.32	-0.05	-0.02	-0.32	-0.65	-0.64	-1.22	-3.84
Net Debt/EBITDA	15.7	0.64	2.1	1.5	1.2	1.96	-0.05	5.42
Total Debt/EBIT	-0.29	-0.04	-0.01	-0.31	-0.62	-0.62	-1.13	-3.03
Net Debt/EBIT	13.94	0.62	2.01	1.45	1.15	1.89	-0.05	4.27
EBITDA to Interest Expense	-163.28	-583.44	-1,112.1	-420.41	-40.5	-23.38	-13.34	-5.03
EBITDA-CapEx/Interest Expense	-419.63	-759.09	-1,267.4	-470.86	-42.56	-24.42	-13.99	-6.36
EBIT to Interest Expense	-183.8	-607.04	-1,163.04	-435.87	-42.2	-24.22	-14.33	-6.38
Interest Expense	- -	- -	- -	1	11	22	22	21
Common Equity/Total Assets	1.33	-44.23	-16.13	-46.46	-72.61	-80.31	-99.49	-112.96
Long-Term Debt/Equity (%)	45.6	- -	0.32	15.94	37.75	26.01	33.23	8.7
Long-Term Debt/Capital (%)	39.33	-4.17	-1.69	-30.74	-41.2	-28.16	-26.38	-5.65
Long-Term Debt/Total Assets (%)	0.92	1.76	0.26	10.9	21.11	17.61	20.7	5.03
Total Debt/Equity (%)	49.91	-4.95	0.56	16.05	38.23	26.26	33.69	41.28
Total Debt/Capital (%)	43.05	-5.02	-2.98	-30.97	-41.73	-28.43	-26.74	-26.78
Total Debt/Total Assets (%)	1.01	2.11	0.47	10.98	21.38	17.78	20.99	23.86
Net Debt to Equity	-2,429.95	67.85	-76.23	-74.22	-70.55	-79.62	1.39	-58.16
Net Debt/Capital (%)	105.01	40.76	80.11	52.34	35.77	40.94	-0.91	23.82
EBITDA	-13	-130	-217	-378	-437	-510	-288	-108
EBITDA-CapEx	-34	-169	-247	-424	-460	-532	-302	-136
Operating Income (Loss)	-15	-135	-227	-392	-456	-528	-310	-136

Liquidity (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.36	1.24	4.38	3.85	3.44	6.05	4.04	1.49
Current Ratio	2.05	1.62	5.14	4.14	3.69	6.92	4.62	1.96
Quick Ratio	2.04	1.52	5.09	4.11	3.59	6.77	4.49	1.88
CFO/Avg Current Liab	- -	-0.58	-1.83	-1.15	-0.76	-1.53	-0.58	-0.22
Common Equity/Total Assets	1.33	-44.23	-16.13	-46.46	-72.61	-80.31	-99.49	-112.96
Long-Term Debt/Equity (%)	45.6	- -	0.32	15.94	37.75	26.01	33.23	8.7
Long-Term Debt/Capital (%)	39.33	-4.17	-1.69	-30.74	-41.2	-28.16	-26.38	-5.65
Long-Term Debt/Total Assets (%)	0.92	1.76	0.26	10.9	21.11	17.61	20.7	5.03
Total Debt/Equity (%)	49.91	-4.95	0.56	16.05	38.23	26.26	33.69	41.28
Total Debt/Capital (%)	43.05	-5.02	-2.98	-30.97	-41.73	-28.43	-26.74	-26.78
Total Debt/Total Assets (%)	1.01	2.11	0.47	10.98	21.38	17.78	20.99	23.86
CFO/Total Liabilities	73.19	-20.23	-179.38	-56.14	-34.31	-65.85	-22.87	-13.7
CFO/CapEx	14.64	-2.12	-7.36	-4.37	-9.04	-17.33	-10.21	-3.5
Altman's Z-Score	0.49	-1.67	15.69	10.15	6.71	9.46	4.66	2.42

Working Capital (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	2.04	1.43	1.1	4.63	5.69	11.79	105.53
Days Sales Outstanding	- -	179.15	255.48	332.54	78.77	64.1	30.97	3.46
Inventory Turnover	- -	- -	- -	- -	10.8	9.68	10.83	14.6
Days Inventory Outstanding	- -	- -	- -	- -	33.79	37.7	33.71	25
Accounts Payable Turnover	- -	- -	0.09	-0.01	3.82	4.96	7.11	7.03
Accounts Payable Turnover Days	- -	140,242.95	4,114.62	-42,776.57	95.57	73.52	51.34	51.92
Cash Conversion Cycle	- -	- -	- -	- -	16.99	28.28	13.34	-23.46
Inventory to Cash Days	- -	- -	- -	- -	44.98	26.4	-2.74	-21.54
Inventories	1	1	2	2	10	19	24	32
Raw Materials	1	1	2	2	7	13	18	24
Work In Process	- -	- -	- -	- -	1	3	4	1
Finished Goods	- -	- -	- -	- -	3	3	2	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	3,327	6,565	7,939	10,595	5,950	4,007
- Cash & Cash Equivalents	210	83	456	689	786	1,278	287	902
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	6	3	123	285	329	351	414
Enterprise Value	-212	-153	2,825	5,806	7,198	9,615	5,178	3,472
Total Capital	10	-121	-113	-397	-682	-1,156	-1,311	-1,545
Total Debt/Capital (%)	43.05	-5.02	-2.98	-30.97	-41.73	-28.43	-26.74	-26.78
Total Debt / EV	-0.02	-0.04	- -	0.02	0.04	0.03	0.07	0.12
EV/Sales	- -	- -	37.66	84.35	61.52	33.72	8.25	3.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	3,327	6,565	7,939	10,595	5,950	4,007
Diluted Enterprise Value	-206	-77	2,875	5,999	7,438	9,646	6,014	3,519
EV per Share	- -	- -	23.91	41.22	45.26	54.6	28.32	18.84
TTM Sales	49	57	75	69	117	285	627	1,029
TTM EBITDA	-13	-130	-217	-378	-437	-510	-288	-108
TTM Operating Income	-15	-135	-227	-392	-456	-528	-310	-136
TTM Cash Flow to Firm	308	-83	-223	-198	-190	-372	-120	-78
TTM Free Cash Flow to Firm	329	-44	-193	-152	-168	-349	-106	-49

Multiples (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-17.26	-42.89	-44.35	-28.59	-45.8	-55.97
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-212	-153	2,825	5,806	7,198	9,615	5,178	3,472
Low Price	- -	- -	24.64	23.41	30.76	42.9	32.08	21.19
EV/Sales	- -	- -	37.66	84.35	61.52	33.72	8.25	3.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-14.28	-13.45	-15.79	-21	-51.84	-20.76
Price/Earnings High	- -	- -	-19.18	-20.24	-20.55	-26.27	-72.45	-28.13
Price/Earnings Low	- -	- -	-10.93	-8.17	-10.96	-14.58	-33.14	-13.16
Price/Book Value	- -	- -	-28.56	-12.62	-8.22	-7.14	-3.58	-2.05
Price/Book Value Average	- -	- -	-32.65	-10.44	-7.29	-7.33	-5.52	-3.15
Price/Book Value High	- -	- -	-43.85	-15.71	-9.49	-9.17	-7.72	-4.26
Price/Book Value Low	- -	- -	-24.99	-6.34	-5.06	-5.09	-3.53	-1.99
Price/Tangible Book Value	- -	- -	5.59	8.76	11.75	9.67	6.87	4.32
Price/Tangible Book Value Average	- -	- -	6.39	7.25	10.43	9.93	10.59	6.64
Price/Tangible Book Value High	- -	- -	8.59	10.91	13.58	12.42	14.8	9
Price/Tangible Book Value Low	- -	- -	4.89	4.4	7.24	6.89	6.77	4.21
Price/Sales	- -	- -	44.36	95.39	67.86	37.16	9.49	3.89
Price/Sales Average	- -	- -	50.72	78.89	60.24	38.17	14.63	5.99
Price/Sales High	- -	- -	68.12	118.7	78.39	47.75	20.44	8.12
Price/Sales Low	- -	- -	38.82	47.91	41.8	26.5	9.35	3.8
Price/Cash Flow	- -	- -	-14.92	-33.08	-39.44	-26.94	-41.32	-39.99
Price/Cash Flow Average	- -	- -	-17.06	-27.36	-35.02	-27.67	-63.72	-61.49
Price/Cash Flow High	- -	- -	-22.91	-41.16	-45.57	-34.62	-89.05	-83.33
Price/Cash Flow Low	- -	- -	-13.05	-16.61	-24.3	-19.21	-40.74	-38.98
Price/Free Cash Flow Average	- -	- -	-19.74	-35.48	-39.38	-29.37	-70.63	-86.06
Price/Free Cash Flow High	- -	- -	-26.51	-53.37	-51.24	-36.74	-98.72	-116.62
Price/Free Cash Flow Low	- -	- -	-15.11	-21.54	-27.32	-20.39	-45.16	-54.55
EV/Sales Average	- -	- -	44.68	70.67	55.96	34.84	14.73	5.51
EV/Sales High	- -	- -	62.09	110.47	74.1	44.43	20.54	7.64
EV/Sales Low	- -	- -	32.79	39.69	37.52	23.17	9.45	3.32
EV/EBITDA Average	15.37	0.59	-15.45	-12.86	-14.97	-19.49	-32.07	-52.73
EV/EBITDA High	15.37	0.59	-21.47	-20.1	-19.83	-24.85	-44.73	-73.06
EV/EBITDA Low	15.37	0.59	-11.34	-7.22	-10.04	-12.96	-20.58	-31.76
EV/EBIT Average	13.66	0.57	-14.78	-12.4	-14.37	-18.81	-29.85	-41.56
EV/EBIT High	13.66	0.57	-20.53	-19.38	-19.03	-23.98	-41.64	-57.59
EV/EBIT Low	13.66	0.57	-10.84	-6.96	-9.63	-12.51	-19.16	-25.04
Last Price	- -	- -	28.16	46.61	49.92	60.17	32.54	21.74
High Price	- -	- -	43.24	58	57.67	77.32	70.13	45.3
Enterprise Value Average	-206	-77	3,351	4,864	6,547	9,934	9,239	5,673
Enterprise Value High	-206	-77	4,657	7,603	8,670	12,666	12,887	7,862
Enterprise Value Low	-206	-77	2,459	2,731	4,390	6,606	5,930	3,418

Profitability (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-37.1	-52.76	-43.83	-36.43	-32.6	-10.06	-17.44
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	44.14	49.42	62.6	60.34
EBITDA Margin (%)	-27.25	-227.21	-289.15	-549.75	-373.68	-178.74	-45.93	-10.46
Operating Margin (%)	-30.68	-236.39	-302.39	-569.97	-389.4	-185.23	-49.34	-13.27
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-3.29	-227.66	-411.05	-591.63	-380.94	-182.46	-25.2	-27.47
Profit Margin (%)	-5.67	-232.21	-355.16	-586.38	-381.48	-181.8	-28.22	-28.85
Net Income to Common Margin (%)	-5.67	-232.21	-355.16	-586.38	-381.48	-181.8	-28.22	-28.85
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	4	6	3	123	285	329	351	414
ST Debt	- -	1	1	1	4	3	5	326
LT Debt	4	5	2	122	281	325	346	87
Total Debt/EBITDA	-0.32	-0.05	-0.02	-0.32	-0.65	-0.64	-1.22	-3.84
Net Debt/EBITDA	15.7	0.64	2.1	1.5	1.2	1.96	-0.05	5.42
Total Debt/EBIT	-0.29	-0.04	-0.01	-0.31	-0.62	-0.62	-1.13	-3.03
Net Debt/EBIT	13.94	0.62	2.01	1.45	1.15	1.89	-0.05	4.27
EBITDA to Interest Expense	-163.28	-583.44	-1,112.1	-420.41	-40.5	-23.38	-13.34	-5.03
EBITDA-CapEx/Interest Expense	-419.63	-759.09	-1,267.4	-470.86	-42.56	-24.42	-13.99	-6.36
EBIT to Interest Expense	-183.8	-607.04	-1,163.04	-435.87	-42.2	-24.22	-14.33	-6.38
Interest Expense	- -	- -	- -	1	11	22	22	21
Common Equity/Total Assets	1.33	-44.23	-16.13	-46.46	-72.61	-80.31	-99.49	-112.96
Long-Term Debt/Equity (%)	45.6	- -	0.32	15.94	37.75	26.01	33.23	8.7
Long-Term Debt/Capital (%)	39.33	-4.17	-1.69	-30.74	-41.2	-28.16	-26.38	-5.65
Long-Term Debt/Total Assets (%)	0.92	1.76	0.26	10.9	21.11	17.61	20.7	5.03
Total Debt/Equity (%)	49.91	-4.95	0.56	16.05	38.23	26.26	33.69	41.28
Total Debt/Capital (%)	43.05	-5.02	-2.98	-30.97	-41.73	-28.43	-26.74	-26.78
Total Debt/Total Assets (%)	1.01	2.11	0.47	10.98	21.38	17.78	20.99	23.86
Net Debt to Equity	-2,429.95	67.85	-76.23	-74.22	-70.55	-79.62	1.39	-58.16
Net Debt/Capital (%)	105.01	40.76	80.11	52.34	35.77	40.94	-0.91	23.82
EBITDA	-13	-130	-217	-378	-437	-510	-288	-108
EBITDA-CapEx	-34	-169	-247	-424	-460	-532	-302	-136
Operating Income (Loss)	-15	-135	-227	-392	-456	-528	-310	-136

Liquidity (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.36	1.24	4.38	3.85	3.44	6.05	4.04	1.49
Current Ratio	2.05	1.62	5.14	4.14	3.69	6.92	4.62	1.96
Quick Ratio	2.04	1.52	5.09	4.11	3.59	6.77	4.49	1.88
CFO/Avg Current Liab	- -	-0.58	-1.83	-1.15	-0.76	-1.53	-0.58	-0.22
Common Equity/Total Assets	1.33	-44.23	-16.13	-46.46	-72.61	-80.31	-99.49	-112.96
Long-Term Debt/Equity (%)	45.6	- -	0.32	15.94	37.75	26.01	33.23	8.7
Long-Term Debt/Capital (%)	39.33	-4.17	-1.69	-30.74	-41.2	-28.16	-26.38	-5.65
Long-Term Debt/Total Assets (%)	0.92	1.76	0.26	10.9	21.11	17.61	20.7	5.03
Total Debt/Equity (%)	49.91	-4.95	0.56	16.05	38.23	26.26	33.69	41.28
Total Debt/Capital (%)	43.05	-5.02	-2.98	-30.97	-41.73	-28.43	-26.74	-26.78
Total Debt/Total Assets (%)	1.01	2.11	0.47	10.98	21.38	17.78	20.99	23.86
CFO/Total Liabilities	73.19	-20.23	-179.38	-56.14	-34.31	-65.85	-22.87	-13.7
CFO/CapEx	14.64	-2.12	-7.36	-4.37	-9.04	-17.33	-10.21	-3.5
Altman's Z-Score	0.49	-1.67	15.69	10.15	6.71	9.46	4.66	2.42

Working Capital (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	2.04	1.43	1.1	4.63	5.69	11.79	105.53
Days Sales Outstanding	- -	179.15	255.48	332.54	78.77	64.1	30.97	3.46
Inventory Turnover	- -	- -	- -	- -	10.8	9.68	10.83	14.6
Days Inventory Outstanding	- -	- -	- -	- -	33.79	37.7	33.71	25
Accounts Payable Turnover	- -	- -	0.09	-0.01	3.82	4.96	7.11	7.03
Accounts Payable Turnover Days	- -	140,242.95	4,114.62	-42,776.57	95.57	73.52	51.34	51.92
Cash Conversion Cycle	- -	- -	- -	- -	16.99	28.28	13.34	-23.46
Inventory to Cash Days	- -	- -	- -	- -	44.98	26.4	-2.74	-21.54
Inventories	1	1	2	2	10	19	24	32
Raw Materials	1	1	2	2	7	13	18	24
Work In Process	- -	- -	- -	- -	1	3	4	1
Finished Goods	- -	- -	- -	- -	3	3	2	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	3,327	6,565	7,939	10,595	5,950	4,007
- Cash & Cash Equivalents	210	83	456	689	786	1,278	287	902
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	6	3	123	285	329	351	414
Enterprise Value	-212	-153	2,825	5,806	7,198	9,615	5,178	3,472
Total Capital	10	-121	-113	-397	-682	-1,156	-1,311	-1,545
Total Debt/Capital (%)	43.05	-5.02	-2.98	-30.97	-41.73	-28.43	-26.74	-26.78
Total Debt / EV	-0.02	-0.04	- -	0.02	0.04	0.03	0.07	0.12
EV/Sales	- -	- -	37.66	84.35	61.52	33.72	8.25	3.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	3,327	6,565	7,939	10,595	5,950	4,007
Diluted Enterprise Value	-206	-77	2,875	5,999	7,438	9,646	6,014	3,519
EV per Share	- -	- -	23.91	41.22	45.26	54.6	28.32	18.84
TTM Sales	49	57	75	69	117	285	627	1,029
TTM EBITDA	-13	-130	-217	-378	-437	-510	-288	-108
TTM Operating Income	-15	-135	-227	-392	-456	-528	-310	-136
TTM Cash Flow to Firm	308	-83	-223	-198	-190	-372	-120	-78
TTM Free Cash Flow to Firm	329	-44	-193	-152	-168	-349	-106	-49

Multiples (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-17.26	-42.89	-44.35	-28.59	-45.8	-55.97
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-212	-153	2,825	5,806	7,198	9,615	5,178	3,472
Low Price	- -	- -	24.64	23.41	30.76	42.9	32.08	21.19
EV/Sales	- -	- -	37.66	84.35	61.52	33.72	8.25	3.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-14.28	-13.45	-15.79	-21	-51.84	-20.76
Price/Earnings High	- -	- -	-19.18	-20.24	-20.55	-26.27	-72.45	-28.13
Price/Earnings Low	- -	- -	-10.93	-8.17	-10.96	-14.58	-33.14	-13.16
Price/Book Value	- -	- -	-28.56	-12.62	-8.22	-7.14	-3.58	-2.05
Price/Book Value Average	- -	- -	-32.65	-10.44	-7.29	-7.33	-5.52	-3.15
Price/Book Value High	- -	- -	-43.85	-15.71	-9.49	-9.17	-7.72	-4.26
Price/Book Value Low	- -	- -	-24.99	-6.34	-5.06	-5.09	-3.53	-1.99
Price/Tangible Book Value	- -	- -	5.59	8.76	11.75	9.67	6.87	4.32
Price/Tangible Book Value Average	- -	- -	6.39	7.25	10.43	9.93	10.59	6.64
Price/Tangible Book Value High	- -	- -	8.59	10.91	13.58	12.42	14.8	9
Price/Tangible Book Value Low	- -	- -	4.89	4.4	7.24	6.89	6.77	4.21
Price/Sales	- -	- -	44.36	95.39	67.86	37.16	9.49	3.89
Price/Sales Average	- -	- -	50.72	78.89	60.24	38.17	14.63	5.99
Price/Sales High	- -	- -	68.12	118.7	78.39	47.75	20.44	8.12
Price/Sales Low	- -	- -	38.82	47.91	41.8	26.5	9.35	3.8
Price/Cash Flow	- -	- -	-14.92	-33.08	-39.44	-26.94	-41.32	-39.99
Price/Cash Flow Average	- -	- -	-17.06	-27.36	-35.02	-27.67	-63.72	-61.49
Price/Cash Flow High	- -	- -	-22.91	-41.16	-45.57	-34.62	-89.05	-83.33
Price/Cash Flow Low	- -	- -	-13.05	-16.61	-24.3	-19.21	-40.74	-38.98
Price/Free Cash Flow Average	- -	- -	-19.74	-35.48	-39.38	-29.37	-70.63	-86.06
Price/Free Cash Flow High	- -	- -	-26.51	-53.37	-51.24	-36.74	-98.72	-116.62
Price/Free Cash Flow Low	- -	- -	-15.11	-21.54	-27.32	-20.39	-45.16	-54.55
EV/Sales Average	- -	- -	44.68	70.67	55.96	34.84	14.73	5.51
EV/Sales High	- -	- -	62.09	110.47	74.1	44.43	20.54	7.64
EV/Sales Low	- -	- -	32.79	39.69	37.52	23.17	9.45	3.32
EV/EBITDA Average	15.37	0.59	-15.45	-12.86	-14.97	-19.49	-32.07	-52.73
EV/EBITDA High	15.37	0.59	-21.47	-20.1	-19.83	-24.85	-44.73	-73.06
EV/EBITDA Low	15.37	0.59	-11.34	-7.22	-10.04	-12.96	-20.58	-31.76
EV/EBIT Average	13.66	0.57	-14.78	-12.4	-14.37	-18.81	-29.85	-41.56
EV/EBIT High	13.66	0.57	-20.53	-19.38	-19.03	-23.98	-41.64	-57.59
EV/EBIT Low	13.66	0.57	-10.84	-6.96	-9.63	-12.51	-19.16	-25.04
Last Price	- -	- -	28.16	46.61	49.92	60.17	32.54	21.74
High Price	- -	- -	43.24	58	57.67	77.32	70.13	45.3
Enterprise Value Average	-206	-77	3,351	4,864	6,547	9,934	9,239	5,673
Enterprise Value High	-206	-77	4,657	7,603	8,670	12,666	12,887	7,862
Enterprise Value Low	-206	-77	2,459	2,731	4,390	6,606	5,930	3,418

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	259	259	266	308	330	364	367	370
Diluted Weighted Avg Shares	100	100	118	141	159	176	183	184
Basic Weighted Avg Shares	100	100	118	141	159	176	183	184
Revenue per Share	0.49	0.57	0.63	0.49	0.74	1.62	3.43	5.58
EBITDA per Share	-0.13	-1.3	-1.84	-2.69	-2.75	-2.89	-1.58	-0.58
Operating Income per Share	-0.15	-1.35	-1.92	-2.79	-2.86	-3	-1.69	-0.74
Basic EPS, GAAP	-0.03	-1.33	-2.25	-2.87	-2.81	-2.94	-0.97	-1.61
Basic EPS from Cont Ops	-0.03	-1.33	-2.25	-2.87	-2.81	-2.94	-0.97	-1.61
Diluted EPS, GAAP	-0.03	-1.33	-2.25	-2.87	-2.81	-2.94	-0.97	-1.61
Diluted EPS from Cont Ops	-0.03	-1.33	-2.25	-2.87	-2.81	-2.94	-0.97	-1.61
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	3.07	-0.83	-1.89	-1.41	-1.27	-2.23	-0.79	-0.54
Free Cash Flow per Basic Share	2.86	-1.22	-2.14	-1.73	-1.41	-2.36	-0.86	-0.7
Cash & Equivalents per Share	2.16	1.59	4.28	6.26	6.45	7.43	6.14	5.15
Book Value per Share	0.06	-1.27	-0.99	-3.69	-6.08	-8.43	-9.09	-10.62
Tangible Book Value per Share	0.09	-1.28	5.04	5.32	4.25	6.22	4.74	5.03

Legend Biotech Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)